Everest Medicines Limited PEG Ratio

The latest PEG ratio for 1952.HK is 163.37. That is above the Healthcare sector average of 11.77. Investors often review this figure alongside Everest Medicines Limited's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, 1952.HK currently prints 163.37 for PEG ratio, while the sector average sits near 11.77. That is roughly 1287.8% above the sector mean. Large gaps often invite a closer look at Everest Medicines Limited's growth, margins, and balance sheet.

A PEG ratio of 163.37 for Everest Medicines Limited is not 'good' or 'bad' on its own. Compare it with the peer average (11.77) and with 1952.HK's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting 1952.HK's PEG ratio (163.37), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Everest Medicines Limited's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.